Lisbeth Bjerring Jensen

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of a Single-Dose of NN2211, a Long-Acting Glucagon-Like Peptide 1 Derivative, in Healthy Male Subjects

B. Elbrønd, Grethe Jakobsen, Søren Erik Larsen et al. · Diabetes Care · 2002 · 282 citations · Full text

Immune Responses to Insulin Aspart and Biphasic Insulin Aspart in People With Type 1 and Type 2 Diabetes

Anders Lindholm, Lisbeth Bjerring Jensen, Philip Home et al. · Diabetes Care · 2002 · 108 citations · Full text

In Vitro Protein Binding of Liraglutide in Human Plasma Determined by Reiterated Stepwise Equilibrium Dialysis

Anne Plum, Lisbeth Bjerring Jensen, Jesper B. Kristensen · Journal of Pharmaceutical Sciences · 2013 · 86 citations · Full text

Hemodialysis, Renal Function, Vitro Protein Binding +9

A New Insulin Immunoassay Specific for the Rapid-Acting Insulin Analog, Insulin Aspart, Suitable for Bioavailability, Bioequivalence, and Pharmacokinetic Studies

Lennart Andersen, P N Jørgensen, Lisbeth Bjerring Jensen et al. · Clinical Biochemistry · 2000 · 68 citations

Pharmacokinetic Studies, Translational Medicine, Diabetes Management +9

Identification and Removal of Polymer‐ and Aggregate‐Forming Proteins in Human Plasma Albumin Preparations

Lisbeth Bjerring Jensen, Jørgen Dam, Børge Teisner · Vox Sanguinis · 1994 · 20 citations